SCHEDULE: Trillium Trading Discloses 18% Stake in WORK Medical

Trillium Trading, LLC has reported beneficial ownership of 18% of WORK Medical Technology Group LTD's Class A Ordinary Shares as of June 3, 2026.

Summary

• Trillium Trading, LLC has filed a Schedule 13G, indicating it beneficially owns 220,000 shares of WORK Medical Technology Group LTD's Class A Ordinary Shares.
• This ownership stake represents 18.0% of the total class of securities.
• The filing date for this event is June 3, 2026.
• Trillium Trading, LLC is a limited liability company organized under the laws of Delaware, USA, with its principal business office located at 417 Fifth Avenue, New York, New York 10016.
• The issuer, WORK Medical Technology Group LTD, has its principal executive offices at 1/88 Cook St, Auckland City, New Zealand, 1001.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of ownership without commentary on the company's performance or future prospects.

Positives

• Trillium Trading, LLC has acquired a significant stake (18%) in WORK Medical Technology Group LTD, which could signal confidence in the company's future prospects.
• The filing indicates Trillium Trading has sole voting and sole dispositive power over these shares, suggesting clear control and intent.

Risks

• The filing does not explicitly detail risks associated with this investment, but any significant ownership by a trading firm can introduce volatility.
• Concentration of ownership in a single entity could potentially lead to market influence that may not align with other shareholders' interests.

Future Outlook

The filing is a disclosure of current ownership and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that significant stake disclosures by entities like Trillium Trading, LLC, often active in trading, can precede or coincide with market movements or strategic shifts for the target company, WORK Medical Technology Group LTD.

Stakeholder Impact

• Shareholders: The significant stake held by Trillium Trading, LLC may influence share price due to potential trading activity or strategic influence.
• Management: The disclosure may prompt management to consider the intentions of a large shareholder.
• Creditors: No direct impact is indicated by this filing.

Next Steps

• Trillium Trading, LLC will continue to hold its shares in WORK Medical Technology Group LTD.
• Further filings may be required if Trillium Trading's ownership stake changes significantly.

Key Dates

Keywords

WORK Medical Technology Group LTD, Trillium Trading, LLC, Schedule 13G, Class A Ordinary Shares, Beneficial Ownership, Securities Filing, Investment, New Zealand Company, US Investor